In Vitro Models of the Intestinal Barrier

Anon. (1997). ECVAM News and Views. ATLA 22, 7–11.

Lennernas H. (1998). Human intestinal permeability. Journal of Pharmaceutical Sciences 87, 403–410.

Tsuji A. , & Tamai I. (1996). Carrier-mediated intestinal transport of drugs. Pharmaceutical Research 13, 963–977.

Pade V. , & Stavchansky S. (1998). Link between drug absorption solubility and permeability measurements in Caco-2 cells. Journal of Pharmaceutical Sciences 87, 1604–1607.

Levin R.J. (1982). Assessing small intestinal function in health and disease in vivo and in vitro. Scandinavian Journal of Gastroenterology 74, 31S–51S.

Wikman A. , Karlsson J. , Carlstedt I. , & Artursson P. (1993). A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H. Pharmaceutical Research 10, 843–852.

Welling P.G. (1984). Interactions affecting drug absorption. Clinical Pharmacokinetics 9, 404–434.

Tietze K.J. , & Putcha L. (1994). Factors affecting drug bioavailability in space. Journal of Clinical Pharmacology 34, 671–676.

Galia E. , Nicolaides E. , Horter D. , Lobenberg R. , Reppas C. , & Dressman J.B. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharmaceutical Research 15, 698–705.

Ansoborlo E. , Henge-Napoli M.H. , Chazel V. , Gibert R. , & Guilmette R.A. (1999). Review and critical analysis of available in vitro dissolution tests. Health Physics 77, 638–645.

Dressman J.B. , Amidon G.L. , Reppas C , & Shah V.P. (1998). Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharmaceutical Research 15, 11–22.

Macheras P. , & Argyrakis P. (1997). Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? Pharmaceutical Research 14, 842–847.

Winne D. (1979). Rat jejunum perfused in situ: effect of perfusion rate and intraluminal radius on absorption rate and effective unstirred layer thickness. Naunyn Schmiedeberg's Archives of Pharmacology 307, 265–274.

Pacha J. (2000). Development of intestinal transport function in mammals. Physiological Reviews 80, 1633–1667.

Kararli T. T. (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharmaceutics and Drug Disposition 16, 351–380.

Wilding I.R. , Kenyon C.J. , & Hooper G. (2000). Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet. Alimentary Pharmacology and Therapeutics 14, 163–169.

White R.E. , & Manitpisitkul P. (2001). Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metabolism and Disposition 29, 957–966.

Yuasa H. , Matsuda K. , & Watanabe J. (1993). Influence of anesthetic regimens on intestinal absorption in rats. Pharmaceutical Research 10, 884–888.

Barthe L. , Woodley J. , & Houin G. (1999). Gastrointestinal absorption of drugs: methods and studies. Fundamental and Clinical Pharmacology 13, 154–168.

Acra S.A. , & Ghishan F.K. (1991). Methods of investigating intestinal transport. Journal of Parenteral and Enteral Nutrition 15, 93S–98S.

Davis G.R. , Santa Ana C.A. , Morawski S.G. , & Fordtran J.S. (1982). Permeability characteristics of human jejunum, ileum, proximal colon and distal colon: results of potential difference measurements and unidirectional fluxes. Gastroenterology 83, 844–850.

Barthe L. , Woodley J.F. , Kenworthy S. , & Houin G. (1998). An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. European Journal of Drug Metabolism and Pharmacokinetics 23, 313–323.

Leppert P.S. , & Fix J.A. (1994). Use of everted intestinal rings for in vitro examination of oral absorption potential. Journal of Pharmaceutical Sciences 83, 976–998.

Chowhan Z.T. , & Amaro A.A. (1977). Everted rat intestinal sacs as an in vitro model for assessing absorptivity of new drugs. Journal of Pharmaceutical Sciences 66, 1249–1253.

Levet-Trafit B. , Gruyer M.S. , Marjanovic M. , & Chou R.C. (1996). Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sciences 58, L359–363.

Ussing H.H. , & Zerahn K. (1951). Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Acta Physiologica Scandinavia 23, 110–127, 1951.

Soderholm J.D. , Hedman L. , Artursson P. , Franzen L. , Larsson J. , Pantzar N. , Permert J. , & Olaison G. (1998). Integrity and metabolism of human ileal mucosa in vitro in the Ussing chamber. Acta Physiologica Scandinavia 162, 47–56.

Friedman E.A. (1981). Differential response of premalignant epithelial cell classes to phorbol ester tumor promoters and to deoxycholic acid. Cancer Research 41, 4588–4599.

Roediger W.E. , & Truelove S.C. (1979). Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut 20, 484–488.

Ishii S. , Steele G. , Ford R. , Paliotti G. , Thomas P. , Andrews C. , Hansen H.J. , Goldenberg D.M. , & Jessup J.M. (1994). Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology 106, 1242–1250.

Goldstein J.L. , Sahi J. , Bhuva M. , Layden T.J. , & Rao M.C. (1994). Escherichia coli heat-stable enterotoxin-mediated colonic Cl^– secretion is absent in cystic fibrosis. Gastroenterology 107, 950–956.

Clausen M.R. , & Mortensen P.B. (1995). Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37, 684–689.

Gibson P. , & Rosella O. (1995). Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 37, 536–543.

Mahida YR ., Makh S. , Hyde S. , Gray T. , & Borriello S.P. (1996). Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38, 337–347.

Branka J.E. , Vallette G. , Jarry A. , Bou-Hanna C. , Lemarre P. , Van P.N. , & Laboisse C.L. (1997). Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology 112, 1887–1894.

Kedinger M. , Haffen K. , & Simon-Assmann P. (1987). Intestinal tissue and cell cultures. Differentiation 36, 71–85.

Gaush C.R. , Hard W.L. , & Smith T.F. (1966). Characterization of an established line of canine kidney cells (MDCK). Proceedings of the Society for Experimental Biology and Medicine 122, 931–935.

Cho M.J. , Thompson D.P. , Cramer C.T. , Vidmar T.J. , & Scieszka J.F. (1989). The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier. Pharmaceutical Research 6, 71–77.

Quaroni A. , Wands J. , Trelstad R.L. , & Isselbacher K.J. (1979). Epithelioid cell cultures from rat small intestine: characterization by morphologic and immunologic criteria. Journal of Cell Biology 80, 248–265.

Blay J. , & Brown K.D. (1984). Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biology International Reports 8, 551–560.

Quaroni A. , & Beaulieu J.F. (1997). Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. Gastroenterology 113, 1198–1213.

Fisher J.M. , Wrighton S.A. , Calamia J.C. , Shen D.D. , Kunze K.L. , & Thummel K.E. (1999). Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding. Journal of Pharmacology and Experimental Therapeutics 289, 1143–1150.

Hu M. , Li Y. , Davitt C.M. , Huang S.M. , Thummel K. , Penman B.W. , & Crespi C.L. (1999). Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharmaceutical Research 16, 1352–1359.

Hunter J. , Hirst B.H. , & Simmons N.L. (1993). Drug absorption limited by P-glycoproteinedi-ated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharmaceutical Research 10, 743–749.

Burton P.S. , Conradi R.A. , Hilgers A.R. , & Ho N.F. (1993). Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochemical and Biophysical Research Communications 190, 760–766.

Carriere V. , Lesuffleur T. , Barbat A , Rousset M. , Dussaulx E. , Costet P. , de Waziers I. , Beaune P. , & Zweibaum A. (1994). Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7 (published erratum appears in FEBS Letters 362, 99 [1995]). FEBS Letters 355, 247–250.

Hilgendorf C. , Spahn-Langguth H. , Regardh C.G. , Lipka E. , Amidon G.L. , & Langguth P. (2000). Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. Journal of Pharmaceutical Sciences 89, 63–75.

Artursson P. , & Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophyical Research Communications 175, 880–885.

Rubas W. , Cromwell M.E. , Shahrokh Z. , Villagran J. , Nguyen T.N. , Wellton M. , Nguyen T.H. , & Mrsny R.J. (1996). Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. Journal of Pharmaceutical Sciences 85, 165–169.

Stewart B.H. , Chan O.H. , Lu R.H. , Reyner E.L. , Schmid H.L. , Hamilton H.W. , Steinbaugh B.A. , & Taylor M.D. (1995). Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharmaceutical Research 12, 693–699.

Gan L.S. , Hsyu P.H. , Pritchard J.F. , & Thakker D. (1993). Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharmaceutical Research 10, 1722–1725.

Lindahl A. , Sandstrom R. , Ungell A.L. , Abrahamsson B. , Knutson T.W. , Knutson L. , & Lennernas H. (1996). Jejunal permeability and hepatic extraction of fluvastatin in humans. Clinical Pharmacology and Therapeutics 60, 493–503.

Fagerholm U. , Johansson M. , & Lennernas H. (1996). Comparison between permeability coefficients in rat and human jejunum. Pharmaceutical Research 13, 1336–1342.

Fine KD ., Santa Ana C.A. , Porter J.L. , & Fordtran J.S. (1993). Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo. Gastroenterology 105, 1117–1125.

Irvine J.D. , Takahashi L. , Lockhart K. , Cheong J. , Tolan J.W. , Selick H.E. , & Grove J.R. (1999). MDCK (Madin Darby canine kidney) cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences 88, 28–33.

Lin J.H. , & Lu A.Y. (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacological Reviews 49, 403–449.

USP (1998). USP, Pharmacopeial forum. US Pharmacopeia 24, 6015–6023.

Lipinski C.A. , Lombardo F. , Dominy B.W. , & Feeney P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 46, 3–26.

Walter E. , Janich S. , Roessler B.J. , Hilfinger J.M. , & Amidon G.L. (1996). HT29-MTX/Caco-2 co-cultures as an in vitro model for the intestinal epithelium: in vitro–in vivo correlation with permeability data from rats and humans. Journal of Pharmaceutical Sciences 85, 1070–1076.

Finnström N. , Thörn M. , Lööf L. , & Rane A. (1998). Gene expression of cytochromes P450 in different parts of the human gastrointestinal tract. 12th International Symposium “Microsomes and Drug Oxidation”, Montpellier (France), p. 343. Stockholm, Sweden: Alpha Visa IST/D098.

Raeissi S.D. , Hidalgo I.J. , Segura-Aguilar J. , & Artursson P. (1999). Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharmaceutical Research 16, 625–632.

Artursson P. , Ungell A.L. , & Lofroth J.E. (1993). Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharmaceutical Research 10, 1123–1129.

Artursson P. (1990). Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Sciences 79, 476–482.

Rubas W. , Jezyk N. , & Grass G.M. (1993). Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharmaceutical Research 10, 113–118.

Chadwick V.S. , Phillips S.F. , & Hofmann A.F. (1977). Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 73, 247–251.

Conradi R.A. , Hilgers A.R. , Ho N.F. , & Burton P.S. (1991). The influence of peptide structure on transport across Caco-2 cells [see comments]. Pharmaceutical Research 8, 1453–1460.

Conradi R.A. , Hilgers A.R. , Ho N.F. , & Burton P.S. (1992). The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharmaceutical Research 9, 435–439.

Gres M.C. , Julian B. , Bourrie M. , Meunier V. , Roques C. , Berger M. , Boulenc X. , Berger Y. , & Fabre G. (1998). Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharmaceutical Research 15, 726–733.

Yamashita S. , Tanaka Y. , Endoh Y , Taki Y. , Sakane T. , Nadai T. , & Sezaki H. (1997). Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption. Pharmaceutical Research 14, 486–491.

Lennernas H. , Nylander S. , & Ungell A.L. (1997). Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharmaceutical Research 14, 667–671.

Artursson P. , & Magnusson C. (1990). Epithelial transport of drugs in cell culture. II. Effect of extracellular calcium concentration on the para-cellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. Journal of Pharmaceutical Sciences 79, 595–600.